United States

Back to map

Showing 321-330 of 346 grants

Title Institution Researcher Program Duration Total Award Amount
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850.000,00
Reducing the Burden of Type 1 Diabetes Using Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances University of California, San Diego Schafer Boeder Improving Lives 01-July-2022 to 30-June-2027 $749.956,58
Assess the antigenic profile in human T1D: from β-cell crinophagy to peripheral blood Washington University Xiaoxiao Wan Cures 01-April-2022 to 31-March-2027 $750.000,00
Transcriptional memory in human islet organogenesis Lundquist Institute for Biomedical Medical Innovation at Harbor‐UCLA Medical Center (The Lundquist Institute) Eiji Yoshihara Cures 01-April-2022 to 31-March-2027 $749.995,50
Clinic-based sleep screening and intervention to improve sleep health in adolescents with type 1 diabetes Regents of the University of Colorado Erin Cobry Transportfolio 01-April-2022 to 31-March-2027 $750.000,00
The Development of 3-β-hydroxybutyrate binding protein based electrochemical micro-sensor and its application for CKM system The University of North Carolina at Chapel Hill Koji Sode Improving Lives 01-October-2022 to 30-September-2026 $799.999,96
Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose University of California, San Diego Joseph Wang Improving Lives 01-October-2022 to 30-April-2027 $867.998,91
Development of Uni-molecular Glucose-responsive Insulin Stanford University Danny Hung-Chieh Chou Improving Lives 01-April-2022 to 31-March-2026 $749.997,90
Prevascularized encapsulation platform with local immunosuppression for Islet transplantation The Methodist Hospital Research Institute Alessandro Grattoni Cures 01-August-2021 to 30-April-2027 $692.000,00
Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) Albert Einstein College of Medicine Jeffrey Gonzalez Improving Lives 01-September-2021 to 30-June-2027 $1.870.600,00